Stem Cell Transplantation Improves Scleroderma
Myeloablative autologous hematopoietic stem cell transplantation resulted in significantly better long-term clinical outcomes —although greater toxicity–in patients with scleroderma than did cyclophosphamide, found atrial published in theNew England Journal of Medicine.
Source: JAMA - Category: General Medicine Source Type: research
More News: General Medicine | Scleroderma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants